1 – 10 of 232
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
(2026) In The journal of prevention of Alzheimer's disease
- Contribution to journal › Article
- 2025
-
Mark
Primary care detection of Alzheimer's disease using a self-administered digital cognitive test and blood biomarkers
- Contribution to journal › Article
-
Mark
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
- Contribution to journal › Article
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
- Contribution to journal › Article
-
Mark
Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers : a longitudinal cohort study
- Contribution to journal › Article
-
Mark
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Plasma biomarker profiles in ageing : decoding neurodegeneration in vivo
- Contribution to journal › Debate/Note/Editorial
-
Mark
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals
- Contribution to journal › Article
